Bestpass, Inc. – Trademark Portfolio

Entity Type: 03

Bestpass, Inc. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 11 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 9 trademarks are registered. Notable registered marks include PAYVIAM, BESTPASS, TAGLOGIC, TOLLOGIC, and COMMERCELOGIC. The owner is based in Albany, NY.

Suite 5

500 New Karner Road

Albany, NY 12205

16 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Bestpass, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (11 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

35
Advertising & Business (5 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Bestpass, Inc. have?

Bestpass, Inc. has 16 U.S. trademarks filed with the USPTO. Of these, 9 registered, 4 abandoned, 3 cancelled.

What trademark classes does Bestpass, Inc. file in?

Bestpass, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are Bestpass, Inc.'s most well-known trademarks?

Bestpass, Inc.'s registered trademark portfolio includes well-known marks such as PAYVIAM, BESTPASS, TAGLOGIC, TOLLOGIC, and COMMERCELOGIC. These are among 9 currently registered trademarks in the portfolio.

What is Bestpass, Inc.'s trademark registration success rate?

Bestpass, Inc. has a 56% trademark registration rate, with 9 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.